Patent details

EP3609497 Title: NIRAPARIB, ABIRATERONE ACETATE AND PREDNISONE FOR TREATING PROSTATE CANCER

Basic Information

Publication number:
EP3609497
PCT Application Number:
US2018026661
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP187208954
PCT Publication Number:
WO2018191141
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NIRAPARIB, ABIRATERONE ACETATE AND PREDNISONE FOR TREATING PROSTATE CANCER
French Title of Invention:
NIRAPARIB, ACÉTATE D'ABIRATÉRONE ET PREDNISONE POUR LE TRAITEMENT DU CANCER DE LA PROSTATE
German Title of Invention:
NIRAPARIB, ABIRATERONACETAT UND PREDNISON ZUR BEHANDLUNG VON PROSTATAKREBS
SPC Number:

Dates

Filing date:
09/04/2018
Grant date:
12/10/2022
EP Publication Date:
19/02/2020
PCT Publication Date:
18/10/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
12/10/2022
EP B1 Publication Date:
12/10/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
09/04/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
05/10/2022
 
 

Name:
Janssen Pharmaceutica NV
Address:
Turnhoutseweg 30, 2340 Beerse, Belgium (BE)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
14/10/2022
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
YU, Margaret K.
Address:
United States (US)

2

Name:
SNYDER, Linda Anne
Address:
United States (US)

Priority

Priority Number:
201762485164 P
Priority Date:
13/04/2017
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/454; A61K 31/573; A61K 31/58; A61P 35/00;

Publication

European Patent Bulletin

1

Issue number:
202241
Publication date:
12/10/2022
Description:
Grant (B1)

2

Issue number:
202332
Publication date:
09/08/2023
Description:
Opposition procedure started

3

Issue number:
202246
Publication date:
16/11/2022
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
30/04/2026
Annual Fee Number:
9
Annual Fee Amount:
115 Euro
Expected Payer:
Last Annual Fee Payment Date:
26/03/2025
Last Annual Fee Paid Number:
8
Last Annual Fee Paid Amount:
99 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
14/10/2022 Power Of Attorney 1
17/10/2022 Outgoing Correspondence 1